Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectationsBusiness live – latest updatesThe owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations. Continue reading...
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Continue reading...
Exclusive: Report says restricting cars and freeing up pavement space could be a cheap way to bring shoppers backThe lon...
Tech firm says it is ‘deeply sorry’ for disruption that took services down and has now addressed the underlying issueWha...
Problem affects businesses, government agencies and even tech firm’s own employeesMicrosoft scrambles to fix global outa...
JLR chief executive calls for EU and Britain to join forces amid competition from Chinese electric carmakersJaguar Land...
Signing of agreement to smooth movement of food, plants and animals next week will not recoup huge sums firms were force...
Increase reported by Aviva after Hastings Direct said claims were up 140% in August and Axa said it had been a ‘surge ye...
No other articles in this category yet.
